Elevance Health Cash on Hand 2010-2023 | ELV
Elevance Health cash on hand from 2010 to 2023. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
- Elevance Health cash on hand for the quarter ending December 31, 2023 was $36.369B, a 6.06% increase year-over-year.
- Elevance Health cash on hand for 2023 was $36.369B, a 6.06% increase from 2022.
- Elevance Health cash on hand for 2022 was $34.292B, a 3.83% increase from 2021.
- Elevance Health cash on hand for 2021 was $33.028B, a 7.47% increase from 2020.
| Elevance Health Annual Cash on Hand (Millions of US $) |
|
|---|---|
| 2023 | $36,369 |
| 2022 | $34,292 |
| 2021 | $33,028 |
| 2020 | $30,733 |
| 2019 | $25,622 |
| 2018 | $22,744 |
| 2017 | $25,057 |
| 2016 | $23,803 |
| 2015 | $21,795 |
| 2014 | $23,061 |
| 2013 | $21,342 |
| 2012 | $21,180 |
| 2011 | $20,189 |
| 2010 | $20,016 |
| 2009 | $21,945 |
| Elevance Health Quarterly Cash on Hand (Millions of US $) |
|
|---|---|
| 2023-12-31 | $36,369 |
| 2023-09-30 | $38,895 |
| 2023-06-30 | $38,284 |
| 2023-03-31 | $38,170 |
| 2022-12-31 | $34,292 |
| 2022-09-30 | $35,901 |
| 2022-06-30 | $33,793 |
| 2022-03-31 | $34,042 |
| 2021-12-31 | $33,028 |
| 2021-09-30 | $33,957 |
| 2021-06-30 | $32,852 |
| 2021-03-31 | $37,511 |
| 2020-12-31 | $30,733 |
| 2020-09-30 | $29,766 |
| 2020-06-30 | $31,516 |
| 2020-03-31 | $25,796 |
| 2019-12-31 | $25,622 |
| 2019-09-30 | $26,925 |
| 2019-06-30 | $25,272 |
| 2019-03-31 | $24,099 |
| 2018-12-31 | $22,744 |
| 2018-09-30 | $24,684 |
| 2018-06-30 | $24,847 |
| 2018-03-31 | $24,701 |
| 2017-12-31 | $25,057 |
| 2017-09-30 | $27,171 |
| 2017-06-30 | $26,567 |
| 2017-03-31 | $27,790 |
| 2016-12-31 | $23,803 |
| 2016-09-30 | $23,619 |
| 2016-06-30 | $23,311 |
| 2016-03-31 | $23,100 |
| 2015-12-31 | $21,795 |
| 2015-09-30 | $22,497 |
| 2015-06-30 | $23,237 |
| 2015-03-31 | $24,354 |
| 2014-12-31 | $23,061 |
| 2014-09-30 | $23,569 |
| 2014-06-30 | $23,972 |
| 2014-03-31 | $23,290 |
| 2013-12-31 | $21,342 |
| 2013-09-30 | $22,061 |
| 2013-06-30 | $21,123 |
| 2013-03-31 | $21,434 |
| 2012-12-31 | $21,180 |
| 2012-09-30 | $22,833 |
| 2012-06-30 | $21,081 |
| 2012-03-31 | $20,437 |
| 2011-12-31 | $20,189 |
| 2011-09-30 | $20,940 |
| 2011-06-30 | $20,369 |
| 2011-03-31 | $20,332 |
| 2010-12-31 | $20,016 |
| 2010-09-30 | $20,964 |
| 2010-06-30 | $19,320 |
| 2010-03-31 | $20,804 |
| 2009-12-31 | $21,945 |
| 2009-09-30 | $18,605 |
| 2009-06-30 | $17,684 |
| 2009-03-31 | $5,441 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $124.869B | $171.340B |
| Elevance Health Inc. operates as a health benefits company. It supports consumers, families and communities across the entire care journey connecting to the care, support and resources to lead healthier lives. Elevance Health Inc., formerly known as Anthem Inc., is based in Indianapolis, Indiana. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cencora (COR) | United States | $48.051B | 19.18 |
| ICON (ICLR) | Ireland | $25.434B | 24.01 |
| DiDi Global (DIDIY) | China | $24.400B | 0.00 |
| Avantor (AVTR) | United States | $16.238B | 23.94 |
| Viatris (VTRS) | United States | $13.880B | 3.96 |
| CochLear (CHEOY) | $13.776B | 0.00 | |
| Revvity (RVTY) | United States | $12.539B | 21.83 |
| Medpace Holdings (MEDP) | United States | $12.267B | 40.36 |
| Charles River Laboratories (CRL) | United States | $11.798B | 21.50 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $11.548B | 0.00 |
| Natera (NTRA) | United States | $11.205B | 0.00 |
| Solventum (SOLV) | United States | $11.115B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $8.282B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $7.290B | 37.01 |
| HealthEquity (HQY) | United States | $6.886B | 51.45 |
| Bausch + Lomb (BLCO) | Canada | $5.197B | 19.99 |
| Organon (OGN) | United States | $4.771B | 4.59 |
| Doximity (DOCS) | United States | $4.444B | 33.08 |
| PACS (PACS) | United States | $3.713B | 0.00 |
| Sotera Health (SHC) | United States | $3.227B | 15.83 |
| Surgery Partners (SGRY) | United States | $3.120B | 28.88 |
| Progyny (PGNY) | United States | $3.079B | 51.68 |
| GoodRx Holdings (GDRX) | United States | $2.840B | 143.80 |
| Life Times (LTH) | United States | $2.783B | 30.76 |
| Premier (PINC) | United States | $2.511B | 9.19 |
| Teladoc Health (TDOC) | United States | $2.203B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $2.164B | 7.00 |
| Agilon Health (AGL) | United States | $2.055B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $1.811B | 0.00 |
| Agiliti (AGTI) | United States | $1.368B | 22.33 |
| NovoCure (NVCR) | Jersey | $1.360B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.331B | 0.00 | |
| Alignment Healthcare (ALHC) | United States | $0.985B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.760B | 7.86 |
| Embecta (EMBC) | United States | $0.594B | 3.92 |
| InnovAge Holding (INNV) | United States | $0.531B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.522B | 0.00 |
| Enhabit (EHAB) | United States | $0.503B | 45.59 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.492B | 0.00 |
| LifeMD (LFMD) | United States | $0.482B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.434B | 0.00 |
| Beauty Health (SKIN) | United States | $0.400B | 0.00 |
| CareDx (CDNA) | United States | $0.391B | 0.00 |
| DocGo (DCGO) | United States | $0.376B | 60.17 |
| MultiPlan (MPLN) | United States | $0.371B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.349B | 0.00 |
| ModivCare (MODV) | United States | $0.335B | 4.44 |
| Sharecare (SHCR) | United States | $0.290B | 0.00 |
| GeneDx Holdings (WGS) | United States | $0.289B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.269B | 0.00 |
| Biodesix (BDSX) | United States | $0.142B | 0.00 |
| So-Young (SY) | China | $0.125B | 41.83 |
| Oncology Institute (TOI) | United States | $0.085B | 0.00 |
| Pono Capital Two (PTWO) | United States | $0.078B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.055B | 0.00 |
| NeueHealth (NEUE) | United States | $0.050B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.035B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.033B | 0.00 |
| Nutex Health (NUTX) | United States | $0.033B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.030B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.029B | 0.00 |
| DermTech (DMTK) | United States | $0.021B | 0.00 |
| OncoCyte (OCX) | United States | $0.021B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.014B | 0.00 |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
| TRxADE HEALTH (MEDS) | United States | $0.009B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.007B | 0.00 |
| OpGen (OPGN) | United States | $0.007B | 0.00 |
| Assure Holdings (IONM) | United States | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |